Amdocs (NASDAQ:DOX – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Monday.
A number of other analysts have also commented on DOX. Stifel Nicolaus began coverage on shares of Amdocs in a research note on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price target for the company. Oppenheimer boosted their target price on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. Finally, Barclays dropped their price target on Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $101.20.
Amdocs Trading Down 0.3 %
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Private Trust Co. NA boosted its holdings in Amdocs by 62.9% in the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock worth $27,000 after buying an additional 117 shares during the period. Brooklyn Investment Group purchased a new stake in shares of Amdocs during the third quarter worth about $28,000. Catalyst Capital Advisors LLC bought a new stake in Amdocs during the 3rd quarter valued at approximately $55,000. GAMMA Investing LLC lifted its holdings in Amdocs by 115.1% in the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after purchasing an additional 428 shares in the last quarter. Finally, Meeder Asset Management Inc. bought a new position in Amdocs in the 3rd quarter worth approximately $77,000. Institutional investors own 92.02% of the company’s stock.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- P/E Ratio Calculation: How to Assess Stocks
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Stock Average Calculator
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- What is the S&P 500 and How It is Distinct from Other Indexes
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.